Plotting the Elimination of Dengue

Article

Dengue is a viral infection spread between humans by Aedes aegypti mosquitoes. Dengue causes flu-like symptoms, including intense headaches and joint pains. Published in the journal Science Translational Medicine, professor Cameron Simmons, from the Department of Microbiology and Immunology at the University of Melbourne and the Peter Doherty Institute for Infection and Immunity, says that a discovery could lead to improved strategies to reduce the incidence of dengue.

"We did a 'real world' experiment and allowed mosquitoes infected with Wolbachia and uninfected mosquitoes to feed on the blood of Vietnamese dengue patients. Our team then measured how efficiently Wolbachia blocked dengue virus infection of the mosquito body and saliva, which in turn steps stops them spreading the virus between humans," Simmons says.

Researchers developed a mathematical model of dengue virus transmission and used the experimental results as a basis to predict how well Wolbachia would reduce the intensity of dengue transmission under a variety of scenarios.

"We found that Wolbachia could eliminate dengue transmission in locations where the intensity of transmission is low or moderate. In high transmission settings, Wolbachia would also cause a significant reduction in transmission.

"Our findings are important because they provide realistic measures of the ability of Wolbachia to block transmission of the dengue virus and provide precise projections of its impact on dengue infections," Simmons says.

Wolbachia has been recently introduced into Cairns and Townsville and the results of this study suggest future dengue outbreaks in these cities should be much less severe than in the past. "Our results will enable policy makers in dengue-affected countries to make informed decisions on Wolbachia when allocating scarce resources to dengue control," Simmons says.

Dengue continues to be a major public health problem in Asia and Latin America. Estimates suggest more than 100 million cases occur globally each year.

Source: University of Melbourne

Related Videos
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud  (Adobe Stock 460719898 by Colored Lights)
Related Content